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The cellular events operating in the regulation of the affinity  I of antibodies produced 
during immunization and the response to different immunizing doses of antigen require 
further investigations. So far most of the experiments in this field have been performed 
at the level of the intact animal and the impact of antigen dose, time after immuniza- 
tion, feedback inhibition by passive antibody, and induction of partial tolerance have 
been studied by determinations of the affinity at the serum level. 
Essentially the findings in this field are: the antigen concentration seems to exert a 
selective pressure at the cellular level in the immune response, so that cells producing 
antibodies with a relatively low affinity for the antigen need a higher concentration of 
antigen  to  become  stimulated  into  antibody  formation  than  cells producing  high 
affinity antibodies. Findings that have been interpreted as consequences of such selec- 
tive processes are: (a)  the gradual increase in affinity with time after immunization 
(1) ; (b) the high doses of antigen initiating the production of antibodies of lower affinity 
than that of antibodies produced as a  response to a  low dose (1,  2);  (c)  the relative 
resistance of high affinity antibody production to feedback inhibition by passive anti- 
body (2); (d) the fact that high affinity antibody is more efficient in feedback inhibition 
than low affinity antibody (3) ; (e) the fact that partially tolerant animals produce anti- 
body with relatively low affinity, i.e., the high affinity cells are more easily paralyzed 
than the low affinity cells (4, 5). 
All the facts and conclusions cited above postulate a similar binding constant (or an 
identity) for the cell-associated antigen-specific receptor and the product of the cell 
released as a result of the combination of the antigen and the receptor. So far the only 
direct evidence for such a mechanism is the finding that there is a correlation between 
the affinity of the antibody produced by immune-cell donor animals and the concentra- 
tion of antigen needed to trigger the immune cells into mitosis in vitro (6). 
The hemolytic plaque assay (7, 8) constitutes an excellent tool to analyze the cellular 
events in the immune response, since it is possible at a  given time to quantitate the 
number of cells producing antibody against a given antigen specificity. Modifications 
* This work was  supported by the Swedish Cancer Society, Anders Otto Sw~irds  Stiftelse, 
Stiftelsen Sigurd och Elsa Goljes Minne,  and Jane Coffin Childs Memorial Fund. 
1  Affinity is the average binding constant in an antibody-hapten system. Avidity is the 
the tendency of an antibody sample to form stable complexes with a macromolecular antigen. 
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have been invented that make it possible to study cells forming antibody against a 
variety  of  proteins  (9-11),  polysaccharides  (12,  13),  synthetic polymers  (14),  and 
haptens (15,  16). The use of specific developing sera for plaque-forming cells (PFC :s) 
allows the separate detection of cells producing antibodies belonging to different im- 
munoglobulin  classes (17, 18) or allotypes (19, 20). 
In the present article the hemolytic plaque  assay has  been adapted  to  the 
study of avidity  I at  the level of the single antibody-forming cell.  The method 
is based upon the principle that hemolytic plaques against sensitized erythro- 
cytes are inhibited by free antigen. The inhibition characteristics of the plaques 
reflect  the  avidity of  the  antibodies released  by the  single hemolytic plaque- 
forming cells (PFC: s).~ The impact of the immunizing dose and of the time after 
immunization has been studied with regard to the avidity both in the serum and 
at the cellular level. 
Material and Methods 
Animals.--Adult inbred mice of (C3H >(  C57BL)F1 genotype were used. In each experi- 
ment animals of the same age and sex were used. 
Immunization.--The mice were immunized by an injection of 0.05 ml of an emulsion of 
Freund's complete adjuvant containing 50 or 5000 #g of bovine serum albumin (BSA) (Mann 
Research Labs, Inc., N.Y., Fraction V), ovalbumin (OA) (Worthington Biochemical  Corp., 
Freehold, N.J., 3X crystallized), or human serum albumin (HSA)  (Kabi,  AB,  Stockholm, 
Sweden)  into each rear footpad. 
Serologic Tests.--B SA was radioiodinated by the chloramine-T  method (2 i). Radioiodinated 
HSA was purchased from Radiochemical Centre, Amersham, England. The antigen-binding 
capacity (ABC) of antisera was determined at 50% binding of antigen by the Farr ammonium 
sulfate method (22) using as standard concentrations 1 and 100/~g of antigen per ml during 
the test. The factor of avidity was calculated according to Celada et al. (5) using the formula: 
log/zl As =  m +  s log #g Ag, 
where s is the slope of the line obtained when microliters of antiserum needed to bind 50% of 
antigen are plotted on a  log/log scale  against #g antigen in the reaction mixture, s is the 
factor of avidity and varies between 0 and 1. A maximal avidity is indicated by values near 
1. m is the intercept with the line log #g Ag =  0. 
Bleeding of Animals  and Preparation of Call Suspensions.--The  mice were  bled from the 
retro=orbital  sinus and thereafter killed by cervical  dislocation. The regional popliteal lymph 
nodes were  harvested in Eagle's medium in Earle (EME)  and single cell suspensions were 
prepared by cutting and squeezing the nodes followed by decantation and washing by cen- 
trlfugation in EME. The suspensions were kept in ice bath until tested. 
Assay for Single Antlbody-Forming Cdls.--Antibody  production against BSA,  HSA,  or 
OA at the single cell level was studied by the hemolytic plaque assay (7, 8). Target cells were 
sheep  erythrocytes coated with the respective albumin by the use of bis diazotized  benzidine 
(10). In order to obtain formation of clear plaques, a concentration of 5 mg of albumin per ml 
2  Abbreviations used in this paper:  ABC, antigen-bindlng capacity; BSA,  bovine serum 
albumin; EME,  Eagle's medium in Earle;  HSA, human serum albumin; OA, ovalbumin; 
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was necessary during the coupling procedure. A rabbit-anti-mouse  immunoglobulin serum 
at a dilution of 1:50 was used to develop the plaques (10). In this system only "developed" 
plaques produced by 7S antibody-releasing ceils were obtained and the serum antibodies are 
found only in the IgG region as shown by gel filtration? 
RESULTS 
Inhibition of Plaque Formation by Free Antigen--Inhibition of plaque forma- 
tion can be expected to occur if fluid antigen is present in the agar in which the 
hemolytic plaque formation takes place.  The free antigen would  compete for 
plaque-producing  antibodies  with  the  antigen  attached  to  the  target erytho- 
cytes. This hypothesis was tested by adding 0.1 ml of phosphate buffered saline 
(PBS) containing dissolved antigen to the liquid agar which was used as the top 
layer immediately before plating. The per cent inhibition was calculated from 
control plates to which 0.1  ml of PBS without antigen had been added.  Cal- 
TABLE I 
Specificity of the Inhibition of Hemolytic Plaque Formation  by Free Antigen 
No. of plagues per aliquot of ceils 
Immunizing antigen  Inhibitor ug per plate  BSA-coated  SRBC  OA-coated  SRBC 
BSA 
OA 
0  416;  492  3;  7 
BSA, 1000  0;  0  2;  2 
OA, 1000  776;  548  1;  1 
0  0;  1  824;  796 
BSA, 1000  0;  0  624;  552 
OA, 1000  0;  0  1;  1 
culations were made from mean values of two to four plates for each amount of 
antigen per plate. 
Table I  shows that specific inhibition can be obtained in this way. A concen- 
tration  of free  BSA  that  completely inhibited  the  plaque  formation  against 
BSA-coated erythrocytes did  not decrease  the  plaque  formation against OA, 
and vice versa. Fig.  1 shows a  typical inhibition curve obtained by adding in- 
creasing amounts of free BSA to the plates in  the  anti-BSA system. The ex- 
perimental variation is indicated by the standard errors of the means. In order 
to express in a simple way the differences in inhibition characteristics between 
different plaque-forming cell  (PFC)  populations, we calculated the concentra- 
tion of antigen in the agar needed to obtain 50% inhibition. 
Detection of Avidity at the Cellular  Level.--The specific inhibition  curves ob- 
tained by adding  increasing  amounts  of dissolved antigen  to  the  agar in  the 
hemolytic plaque  system  (Fig.l)  is  presumably  caused  by  the  formation  of 
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relatively stable complexes between the free antigen and the antibody released 
by the PFC: s. It is logical to assume that the binding constant for the revers- 
ible antigen-antibody reaction would influence the antigen concentration neces- 
sary to neutralize the antibodies so that the hemolytic plaque formation is in- 
hibited, i.e.,  the antibodies are prevented from reaching the antigen attached to 
the  erythrocytes.  This  assumption  was  tested  by  comparing  the  inhibition 
curves obtained with PFC:s from donor animals showing different avidity of 
their serum antibodies. It can be seen in Fig. 2 that a marked difference in in- 
hibition  characteristics  was  obtained.  PFC: s from animals  with  low avidity 
serum antibodies required a higher antigen concentration in the agar to become 
inhibited  than the high avidity PFC: s.  In order to test whether these differ- 
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FIG. 1. Specific inhibition of hemolytic plaque formation against BSA-coated erythrocytes. 
Each point is the mean of four plates and vertical bars indicate SE. 
ences really were reflecting the avidity, antibodies released by the PFC: s were 
first allowed to attach to the target erythrocytes and thereafter elution by free 
antigen was  performed.  The  outcome  of such an experiment is shown in Fig. 
3.  It is  obvious  that  the  plaques  that  are  more  easily inhibited  by antigen 
incorporated into the agar  are  also  more resistant  to  elution  by free  antigen 
added  to  the  plates  after cellular  release  of antibody.  These  findings  are  in 
perfect agreement with the concept that the described inhibition method detects 
differences  in  the avidity for the antigen  at  the cellular production level. 
The Effect of Time after Immunization upon the Avidity of Antibodies Released 
by PFC:s--A gradual increase in avidity or affinity with time after immuniza- 
tion has been reported in a variety of different systems (1, 22-25). It was there- 
fore investigated whether such an impact of time after immunization could be 
detected  also in  the  present,  single  cell system.  In Tables II-IV it is shown 
that  the  avidity  of  anti-BSA  and  anti-HSA  antibodies  released  by  PFC:s 
increases with time after immunization.  Serum antibody determinations were BIRGER ANDERSSON  81 
also made and the avidity in the serum increased in parallel with the avidity 
at the PFC level. It should be noted here that only PFC:s from the regional 
lymph nodes were  tested,  whereas  serum antibody also is contributed  to by 
production from other loci, such as spleen and other lymph nodes. 
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FIG. 2. Specific inhibition of hemolytic plaque formation against BSA-eoated erythrocytes. 
A comparison between PFC populations from animals with different avidity of their serum 
antibodies.  O  O  serum factor  of avidity 0.17, []  []  serum factor  of avidity 0.63, 
•  •  serum factor of avidity 0.97. Each PFC sample is a pool from the regional lymph 
nodes of four animals. The serum avidity was determined on the pooled sera from these 
animals. Each point is the mean value of duplicate or triplicate plates. 
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Fie.. 3. Specific inhibition of hemolytic plaque formation against BSA-coated erythrocytes. 
A comparison between the effect of (a) having the antigen incorporated in the agar during 
the period of antibody release from the PFC :s and (b) the effect of adding the antigen to the 
plates after the period of antibody release from the PFC:s. 4 ml of PBS containing 0-1000 
/zg BSA per ml was added to each plate.  •  •  PFC pool from three animals with serum 
factor of avidity 0.46. O  O PFC pool from three animals with serum avidity 0.39. 
The Effect of the Immunizing Dose upon the Avidity of Antibodies Released by 
PFC:s.--Another  parameter  which  in other  systems has  been shown  to  in- 
fluence the avidity or affinity of antibodies is the immunizing dose  (1,  2).  In 
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released from PFC:s in animals immunized with 50  and 5000 ~g of BSA re- 
spectively. It can be seen that at day 7 after immunization, PFC:s from the 
50 #g group were inhibited 50 %  by 6.4 #g BSA/ml agar whereas the PFC: s 
from the 5000 #g group required 83.3/zg/ml for 50%  inhibition. At days  11 
and 14 differences can also be seen between the groups but an increase in the 
avidity in both groups due to the time factor is also observed. At day 30 the 
TABLE  II 
Variations in the Avidity of the Antibody  Response of Mice Immunized with 50 Izg of BSA 
into Each Hind Footpad. A  Comparison between Serum Antibodies 
and  Antibodies  Released by  PFC:s 
Serum antibodies  Plaque-forming cells 
PFC:s in the  Agar plates 
Day  ABC:~ at 1 ~/ml  ABC at  100 v/ml  Factor of avidity  regional lymph  giving 50% 
nodes  inhibition* 
anti~n/ml 
7  11.12  64.95  0.62  0.56  2000  6.40 
5.02  50.0  0.50  1840 
11.86  84.13  0.57  390 
11  62.4  398.29  0.60  0.56  1160  1.92 
186.0  526.47  0.77  1050 
25.7  374.71  0.42  265 
27.8  469.42  0.39  255 
14  97.5  694.3  0.57  0.57  2800  1.50 
121.5  723.65  0.61  1960 
40.50  410.63  0.50  1820 
159.9  1050.21  0.59  1780 
30  118.04  126.91  0.98  0.95  1340  0.58 
94.52  129.31  0.93  360 
29.59  44.40  0.91  360 
104.23  121.85  0.97  2800 
* The cells from the regional lymph 
antigen. 
:~g BSA bound per ml of serum. 
nodes were pooled and tested for inhibition by free 
groups are shown to be practically equalized. The values for the avidity of the 
serum  antibodies  are  showing  similar differences  as  those  recorded  for  the 
antibodies released from the PFC:s. 
Test for the Presence of Free Antigen in the PFC Suspensions.--The  test cell 
suspensions might  contain remaining free  antigen in  amounts  sufficient  to 
interfere with plaque formation and thus create artificial inhibition differences 
when  cells  from  animals immunized with  different  doses  or  immunized at BIRGER  ANDERSSON  83 
different times before testing are compared. Table V  shows a mixture experi- 
ment where we tested whether PFC: s from animals immunized with 5000/zg 
and showing low avidity both at the serum level and at the cellular produc- 
tion level  interfered with  plaque  formation when  mixed with  PFC:s  from 
animals immunized with 50/zg and showing high avidity both in the serum 
and when the PFC:s were tested. The data gave no indication that the two 
TABLE III 
Variations  in the Avidity of the Antibody Response  of Mice Immunized  with 5000 #g of BSA 
into  Each Hind Footpad: A  Comparison  between Serum Antibodies 
and  Antibodies  Rdeased  by  PFC:s 
Serum antibodies  Antibody forming cells 
PFC:s in the  Agar plates 
Day  ABC~t at 1  g/ml  ABC at  100 ~/ml  Factor  of avidity  regional  lymph  giving  50% 
nodes  inhibition* 
g antlgen/ml 
7  0.62  20.52  0.24  0.17  195  83.30 
0.82  20.52  0.30  70 
0.63  55.81  0.03  110 
1.00  17.07  0.38  275 
11  17.77  296.11  0.39  0.43  135  11.50 
22.42  337.02  0.41  260 
31.85  316.95  0.50  215 
26.82  350.07  0.44  510 
14  14.35  232.78  0.39  0.43  505  8.00 
17.08  160.66  0.51  6080 
20.79  329.89  0.40  900 
18.06  256.91  0.42  200 
30  61.80  100.60  0.89  0.97  520  1.25 
249.20  181.09  1.07  760 
234.88  228.88  1.01  1960 
231.35  332.35  0.92  500 
* See  footnote to Table II. 
See footnote to Table II. 
cell suspensions interfered with each other. Thus, it seems fair to conclude that 
presence of free antigen plays no detectable role in this test system. 
DISCUS  SION 
This article describes an inhibition method for antibodies produced by single 
hemolytic plaque-forming cells in vitro. The avidity of the antibodies produced 
by the PFC: s is reflected by the relative sensitivity of the plaques to inhibition 
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TABLE IV 
Variation  in the Avidity of the Antibody  Response  of Mice Immunized  with 5000 #g of HSA 
into Each Hind Footpad:  A  Comparison  between Serum Antibodies 
and  Antibodies  Released by  PFC:s 
Serum antibodies  Antibody-forming  cells 
PFC:s in the  Agar plates 
Day  ABC~ at 1 tt/ml  ABC at  100 #/mI  Factor  of avidity  regional  lymph  giving  50~ 
node  inhibition* 
#g ant~en/ml 
18  22.07  207.21  0.51  0.50  1380  3.19 
11.03  107.61  0.51  820 
13.90  132.01  0.51  325 
14.72  137.99  0.51  1200 
15.15  200.29  0.44  375 
25  67.38  170.83  0.80  0.62  835  1.73 
90.65  557.17  0.61  2010 
26.47  268.88  0.50  1490 
66.73  686.63  0.49  1255 
308.38  936.04  0.76  2350 
33  127.72  510.20  0.70  0.63  340  0.16 
48.95  659.43  0.44  430 
110.58  669.12  0.61  205 
137.92  325.31  0.81  1760 
* See  footnote to Table II. 
:~ Micrograms of HSA bound per milliliter of serum. 
TABLE V 
The Effect  of Mixing Plaque Forming Cells from Animals Immunized with a High and  a Low 
Dose of A ntigen 
Cell suspension  Plaques  per plate*  Mixture of cell suspeasions:~ 
Plaques per plate* 
Expected  Obtained 
5000  A§  5.5  5000  A  +  50  A  667.5  689.0 
5000  B  10.5  5000  B  +  50 B  22.0  20.5 
5000  C  59.0  5000  C  +  50  C  67.5  72.5 
50  A  662.0  5000  C  -5  50  A  721.0  796.0 
50  B  11.5  5000  A  +  50  C  14.0  20.0 
50  C  8.5  5000  B  +4-  50  C  19.0  13.0 
5000  A  +  50 B  17.0  24.0 
--4 
1528.0  1635.5  Total 
* Mean value of two plates made from 0.1 ml of cell suspension. 
:~ Mixtures were prepared by adding 0.1  ml of each cell suspension to the plates. 
§ The figure indicates immunizing  dose of BSA per foot pad and A, B, and C is identifica- 
tion of the cell donor. The test was performed on day 10 after immunization. A pool of sus- 
pensions 5000 A-C was inhibited 50% by 23.93 #g of BSA per ml of agar and a pool of sus- 
pensions 50 A-C by 0.77 #g of BSA per ml of agar. BIRGER ANDERSSON  85 
concentrations  for  inhibition  than  high  avidity  plaques.  Also  in  agreement 
with the concept of avidity is the finding that high avidity plaques are more 
resistant to inhibition by elution when free antigen is added to the plates after 
the antibodies are released from the PFC: s and attached to the target erythro- 
cytes.  Control  experiments showed  that free  antigen  was  not  transferred to 
the  plates  by  the  immune  cell  suspension  in  quantities  that  interfere with 
plaque formation. 
It was found that both immunizing dose and time after immunization  were 
important factors determining the avidity both  at the serum level and when 
testing  the  PFC:s  by inhibition.  In  essence,  the significance of  the  findings 
described in this article is that it has been possible to show  directly at the cel- 
lular level differences in avidity of antibody produced.  The binding properties 
of the antibody synthetized vary with antigen dose and time after immuniza- 
tion, and the variations observed in the serum are not merely reflecting adsorp- 
tion  of  antibody by  the  administered  antigen.  It would  otherwise  be  quite 
feasible to postulate a preferential adsorption of the antibody with the highest 
affinity for the antigen,  thus creating variations in  the serum both as far as 
dose of antigen and time after immunization are concerned. 
Some other advantages of the PFC inhibition method as compared to studies 
of affinity or avidity at the serum level can be noted: it is possible to determine 
at a given time the binding characteristics of the antibodies produced whereas 
determinations  at  the  serum level reflect the  cumulated  antibody produced 
during a  time period preceding the bleeding. It is also obvious that in experi- 
ments designed to study population kinetics in the induction of avidity changes 
by passive antibody or by paralyzing doses of antigen the present method allows 
the elimination of both antigen and antibody present in the circulation, since 
the PFC suspensions are washed prior to testing. 
A disadvantage of the method is that PFC: s are relatively sensitive to vari- 
ations  in  experimental  conditions,  and  thus  results  obtained  from different 
experiments may not be strictly comparable.  The most  reliable  way  to  get 
information regarding avidity differences is  to compare PFC  populations by 
testing them the same day and under identical conditions. Most of the experi- 
ments described in this article have been conducted in this way. 
The findings in this article are in agreement with earlier reports on the affinity 
of antibodies produced in vitro (26). These workers studied the antibody secreted 
into the supernatants of tissue-cultured lymph node cells by the use of incor- 
poration of radioactive amino acids. Although a good deal of information could 
be obtained by that method, the method in some respects has the same limita- 
tions as determinations performed at the serum level; i.e., adsorption by antigen 
possibly being present in the immune cultures can not be excluded as definitely 
as in the present PFC system where the immune cells are separated from each 
other in  the agar,  and  also where the short time needed to perform the test 
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Experiments  on the influence of the number of haptens  coupled to erythro- 
cytes on hemolytic plaque formation have recently been reported  (16).  It was 
found that early in the immune response the plaque formation was more effi- 
cient  with  a  high  hapten  density  on  the  erythrocytes,  whereas  later  in  the 
immune response plaques  were also formed with  a  lower hapten  density.  The 
differences observed in this case were most likely due to affinity changes. 
SUMMARY 
The hemolytic plaque formation of cells producing antibody against hetero- 
logous albumins was tested for sensitivity to specific inhibition by free antigen. 
The  inhibition  characteristics  of plaques  in  this  system were  found  to  be  a 
measure for the avidity of the antibody produced by the plaque-forming  cells 
(PFC:s).  High  avidity-producing  PFC:s  were  more  sensitive  to  inhibition 
than  low  avidity PFC:s.  Immunization  with  a  high  dose  of  antigen induced 
PFC: s that produced antibody with  a  lower  avidity as  compared  to  PFC: s 
from  animals  immunized  with  a  low  dose.  The  avidity was  increased  with 
time.  Determinations  of avidity  at  the  serum level  were  also made,  and the 
results were in agreement with the findings at the cellular  level. 
The present  method made it possible  to demonstrate  differences in avidity 
of antibody at the level  of the single antibody-forming cell.  It may also con- 
stitute  a  useful  tool for the  analysis  of the cellular events leading  to the pro- 
duction of antibodies with varying affinities during the immune response. 
The author wishes to thank Doctors F.  Celada and H. Wigzell for helpful criticism of the 
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